butyl-delta(9)-tetrahydrocannabinol
- CAS No.
- 60008-00-6
- Chemical Name:
- butyl-delta(9)-tetrahydrocannabinol
- Synonyms
- Δ9-THCB;Δ9-THCB (CRM);butyl-delta(9)-tetrahydrocannabinol;Delta9-Tetrahydrocannabibutol (Delta9-THCB) solution;(6aR,10aR)-3-butyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol;6H-Dibenzo[b,d]pyran-1-ol, 3-butyl-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-, (6aR-trans)-
- CBNumber:
- CB31327149
- Molecular Formula:
- C20H28O2
- Molecular Weight:
- 300.44
- MDL Number:
- MOL File:
- 60008-00-6.mol
- MSDS File:
- SDS
| Boiling point | 375.7±42.0 °C(Predicted) |
|---|---|
| Density | 1.024±0.06 g/cm3(Predicted) |
| storage temp. | -10 to -25°C |
| solubility |
DMF: 50 mg/ml DMF: PBS (pH 7.2) (1:3): 0.25 mg/ml DMSO: 60 mg/ml Ethanol: 35 mg/ml Methanol: 30 mg/ml |
| pka | 9.78±0.60(Predicted) |
| FDA UNII | LIC9QAS59U |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS02,GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H225-H312+H332-H319 | |||||||||
| Precautionary statements | P210-P233-P240-P241-P242-P243-P261-P264-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P312-P321-P362+P364-P337+P313-P370+P378-P403+P235-P501 | |||||||||
| target organs | Eyes,Central nervous system | |||||||||
| WGK Germany | WGK 2 | |||||||||
| Storage Class | 3 - Flammable liquids | |||||||||
| Hazard Classifications | Acute Tox. 3 Dermal Acute Tox. 3 Inhalation Acute Tox. 3 Oral Flam. Liq. 2 STOT SE 1 |
|||||||||
| NFPA 704 |
|
butyl-delta(9)-tetrahydrocannabinol price More Price(9)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 29306 | Δ9-THCB ≥95% | 60008-00-6 | 1mg | $129 | 2026-04-30 | Buy |
| Cayman Chemical | 33078 | Δ9-THCB (CRM) | 60008-00-6 | 1mg | $188 | 2026-04-30 | Buy |
| Cayman Chemical | 29306 | Δ9-THCB ≥95% | 60008-00-6 | 5mg | $510 | 2026-04-30 | Buy |
| Biosynth | KCA00800 | Δ9-THCB, 1mg/ml in acetonitrile | 60008-00-6 | 1mg | $454.3 | 2026-06-04 | Buy |
| Biosynth | KCA00800 | Δ9-THCB, 1mg/ml in acetonitrile | 60008-00-6 | 2mg | $649 | 2026-06-04 | Buy |
butyl-delta(9)-tetrahydrocannabinol Chemical Properties, Uses, Production
Uses
Δ9-THCB (Δ9-Tetrahydrocannabutol) has a high affinity for human CB1 and CB2 receptors with the Ki values of 15 nM and 51 nM, respectively. Δ9-THCB (Δ9-Tetrahydrocannabutol) has analgesic and anti-inflammatory activities and plays partial agonistic effects on CB1 receptor in mice[1].
IC 50
CB1: 15 nM (Ki); CB2: 51 nM (Ki)
References
[1] Linciano P, et al. Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol. J Nat Prod. 2020 Jan 24;83(1):88-98. DOI:10.1021/acs.jnatprod.9b00876
[2] SMITH R. IDENTIFICATION OF BUTYL CANNABINOIDS IN MARIJUANA[J]. Journal of forensic sciences, 1997, 21 1: 610-618. DOI: 10.1520/jfs14173j
[3] HARVEY D I. Characterization of the butyl homologues of Δ1-tetrahydrocannabinol, cannabinol and cannabidiol in samples of cannabis by combined gas chromatography and mass spectrometry[J]. Journal of Pharmacy and Pharmacology, 1976, 28 4: 280-285. DOI: 10.1111/j.2042-7158.1976.tb04153.x
